chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Little soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Little soreness in arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Little soreness in arm). At the time of the report, PAIN IN EXTREMITY (Little soreness in arm) outcome was unknown.            Concomitant medication were not provided by the reporter. Treatment medication were not provided by the reporter.  Action taken with mRNA-1273 in response to the events was Not Applicable   This case was linked to MOD-2021-013942 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal dreams, Body temperature, Chills, Dizziness, Nausea
Clinical narrative: uncomfortable dreams; I had some itchiness and redness at the site; had some itchiness and redness at the site; felt woozy; fever 100.5; chills; nauseous in the morning; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (felt woozy), ABNORMAL DREAMS (uncomfortable dreams), VACCINATION SITE PRURITUS (I had some itchiness and redness at the site), PYREXIA (fever 100.5) and CHILLS (chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure increased, Sleep apnea since 08-Jan-2017, Penicillin allergy, Allergy to antibiotic, Fruit allergy and Allergy to antibiotic. Concomitant products included IRBESARTAN from 01-Jan-2000 to an unknown date for Blood pressure high, ESTROGEN NOS;PROGESTERONE from 01-Jan-2003 to an unknown date for Hormone replacement therapy, VITAMINS NOS for an unknown indication.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced DIZZINESS (felt woozy), PYREXIA (fever 100.5), CHILLS (chills) and NAUSEA (nauseous in the morning). On an unknown date, the patient experienced ABNORMAL DREAMS (uncomfortable dreams), VACCINATION SITE PRURITUS (I had some itchiness and redness at the site) and VACCINATION SITE ERYTHEMA (had some itchiness and redness at the site). At the time of the report, DIZZINESS (felt woozy), ABNORMAL DREAMS (uncomfortable dreams), VACCINATION SITE PRURITUS (I had some itchiness and redness at the site), PYREXIA (fever 100.5), CHILLS (chills), NAUSEA (nauseous in the morning) and VACCINATION SITE ERYTHEMA (had some itchiness and redness at the site) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Mar-2021, Body temperature: 100.5 (High) fever 100.5.         This case was linked to MOD-2021-042134 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: uncomfortable dreams; I had some itchiness and redness at the site; had some itchiness and redness at the site; felt woozy; fever 100.5; chills; nauseous in the morning; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (felt woozy), ABNORMAL DREAMS (uncomfortable dreams), VACCINATION SITE PRURITUS (I had some itchiness and redness at the site), PYREXIA (fever 100.5) and CHILLS (chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure increased, Sleep apnea since 08-Jan-2017, Penicillin allergy, Allergy to antibiotic, Fruit allergy and Allergy to antibiotic. Concomitant products included IRBESARTAN from 01-Jan-2000 to an unknown date for Blood pressure high, ESTROGEN NOS;PROGESTERONE from 01-Jan-2003 to an unknown date for Hormone replacement therapy, VITAMINS NOS for an unknown indication.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced DIZZINESS (felt woozy), PYREXIA (fever 100.5), CHILLS (chills) and NAUSEA (nauseous in the morning). On an unknown date, the patient experienced ABNORMAL DREAMS (uncomfortable dreams), VACCINATION SITE PRURITUS (I had some itchiness and redness at the site) and VACCINATION SITE ERYTHEMA (had some itchiness and redness at the site). At the time of the report, DIZZINESS (felt woozy), ABNORMAL DREAMS (uncomfortable dreams), VACCINATION SITE PRURITUS (I had some itchiness and redness at the site), PYREXIA (fever 100.5), CHILLS (chills), NAUSEA (nauseous in the morning) and VACCINATION SITE ERYTHEMA (had some itchiness and redness at the site) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Mar-2021, Body temperature: 100.5 (High) fever 100.5.         This case was linked to MOD-2021-042134 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Pain in extremity
Clinical narrative: major pain; froze arm; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (froze arm) and PAIN IN EXTREMITY (major pain) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Patient medication history was not provided by the reporter.     On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced LIMB DISCOMFORT (froze arm). On an unknown date, the patient experienced PAIN IN EXTREMITY (major pain). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, LIMB DISCOMFORT (froze arm) and PAIN IN EXTREMITY (major pain) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medication was reported.   This case was linked to MOD-2021-040665 (Patient Link).
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Medication error
Clinical narrative: Received a dose of the Pfizer BioNTech Covid vaccine yesterday, however a month ago she received a dose of the Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of MEDICATION ERROR (Received a dose of the Pfizer BioNTech Covid vaccine yesterday, however a month ago she received a dose of the Moderna vaccine) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 23-Mar-2021, the patient started TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MEDICATION ERROR (Received a dose of the Pfizer BioNTech Covid vaccine yesterday, however a month ago she received a dose of the Moderna vaccine). On 23-Mar-2021, MEDICATION ERROR (Received a dose of the Pfizer BioNTech Covid vaccine yesterday, however a month ago she received a dose of the Moderna vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient received a dose of the Pfizer BioNTech Covid vaccine on 23-Mar-2021, however a month ago she received a dose of the Moderna vaccine.  Concomitant product use was not provided by the reporter.   ? No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Malaise, Pyrexia
Clinical narrative: Feeling Sick; Fever; Tired; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling Sick), PYREXIA (Fever) and FATIGUE (Tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jun-2021 at 5:00 PM, the patient experienced MALAISE (Feeling Sick), PYREXIA (Fever) and FATIGUE (Tired). At the time of the report, MALAISE (Feeling Sick) outcome was unknown and PYREXIA (Fever) and FATIGUE (Tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Two brothers and her mom of reporter received Moderna vaccine.   No concomitant medication was reported. The treatment information was not given.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: NNI
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Dark circles under eyes, Diarrhoea, Fatigue, Hypoaesthesia
Clinical narrative: Malaise; Stomach pain; Dark circles under eyes; Both arms go numb all the way to pink; Diarrhoea; Fever; Fatigue; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Malaise), ABDOMINAL PAIN UPPER (Stomach pain), DARK CIRCLES UNDER EYES (Dark circles under eyes), HYPOAESTHESIA (Both arms go numb all the way to pink) and DIARRHOEA (Diarrhoea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 20-May-2021, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Malaise), ABDOMINAL PAIN UPPER (Stomach pain), DARK CIRCLES UNDER EYES (Dark circles under eyes), HYPOAESTHESIA (Both arms go numb all the way to pink), DIARRHOEA (Diarrhoea), PYREXIA (Fever), FATIGUE (Fatigue) and NAUSEA (Nausea). At the time of the report, MALAISE (Malaise), ABDOMINAL PAIN UPPER (Stomach pain), DARK CIRCLES UNDER EYES (Dark circles under eyes), HYPOAESTHESIA (Both arms go numb all the way to pink), DIARRHOEA (Diarrhoea), PYREXIA (Fever), FATIGUE (Fatigue) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were provided. No concomitant medication information was provided.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Malaise, Nausea, Pyrexia
Clinical narrative: Malaise; Stomach pain; Dark circles under eyes; Both arms go numb all the way to pink; Diarrhoea; Fever; Fatigue; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Malaise), ABDOMINAL PAIN UPPER (Stomach pain), DARK CIRCLES UNDER EYES (Dark circles under eyes), HYPOAESTHESIA (Both arms go numb all the way to pink) and DIARRHOEA (Diarrhoea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 20-May-2021, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Malaise), ABDOMINAL PAIN UPPER (Stomach pain), DARK CIRCLES UNDER EYES (Dark circles under eyes), HYPOAESTHESIA (Both arms go numb all the way to pink), DIARRHOEA (Diarrhoea), PYREXIA (Fever), FATIGUE (Fatigue) and NAUSEA (Nausea). At the time of the report, MALAISE (Malaise), ABDOMINAL PAIN UPPER (Stomach pain), DARK CIRCLES UNDER EYES (Dark circles under eyes), HYPOAESTHESIA (Both arms go numb all the way to pink), DIARRHOEA (Diarrhoea), PYREXIA (Fever), FATIGUE (Fatigue) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were provided. No concomitant medication information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Pyrexia
Clinical narrative: Malaise; Fever; This spontaneous case was reported by a non-health professional and describes the occurrence of MALAISE (Malaise) and PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Malaise) and PYREXIA (Fever). At the time of the report, MALAISE (Malaise) and PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No information on concomitant medication was provided.  No information on treatment medication was provided.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site discolouration
Clinical narrative: the injection site, it is a white spot rectangular in shape; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (the injection site, it is a white spot rectangular in shape) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039B21A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (the injection site, it is a white spot rectangular in shape). At the time of the report, VACCINATION SITE DISCOLOURATION (the injection site, it is a white spot rectangular in shape) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: patient received second dose 20 days after first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received second dose 20 days after first dose) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024C21A and 016C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received second dose 20 days after first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient received second dose 20 days after first dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not Applicable. Concomitant and treatment information not provided
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Skin irritation
Clinical narrative: Pain in right leg; Neck is itching and irritating; Irritating like a ship of glass poking in her skin; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in right leg), PRURITUS (Neck is itching and irritating) and SKIN IRRITATION (Irritating like a ship of glass poking in her skin) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination.     Concomitant products included HYDROCHLOROTHIAZIDE for Blood pressure management.    On 03-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in right leg), PRURITUS (Neck is itching and irritating) and SKIN IRRITATION (Irritating like a ship of glass poking in her skin). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Pain in right leg), PRURITUS (Neck is itching and irritating) and SKIN IRRITATION (Irritating like a ship of glass poking in her skin) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Injection site pain, Pyrexia, Urinary tract infection
Clinical narrative: Urinary Tract Infection; soreness in the injection site; slight fever of 100.5; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (Urinary Tract Infection), INJECTION SITE PAIN (soreness in the injection site) and PYREXIA (slight fever of 100.5) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 015MZ0A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced INJECTION SITE PAIN (soreness in the injection site) and PYREXIA (slight fever of 100.5). On an unknown date, the patient experienced URINARY TRACT INFECTION (Urinary Tract Infection). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form and SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM) ongoing since an unknown date at a dose of UNK mg. On 12-Mar-2021, INJECTION SITE PAIN (soreness in the injection site) and PYREXIA (slight fever of 100.5) had resolved. At the time of the report, URINARY TRACT INFECTION (Urinary Tract Infection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Body temperature: 100.5 (High) fever-100.5.         Action taken in response to mRNA-1273 was not applicable.   This case was linked to MOD-2021-044569 (Patient Link).
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Myalgia, Nausea, Vomiting
Clinical narrative: Diarrhea; Nauseous; Vomitting; Tiredness; Bodyaches; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), FATIGUE (Tiredness), MYALGIA (Bodyaches), NAUSEA (Nauseous) and VOMITING (Vomitting) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jun-2021, the patient experienced FATIGUE (Tiredness) and MYALGIA (Bodyaches). On an unknown date, the patient experienced DIARRHOEA (Diarrhea), NAUSEA (Nauseous) and VOMITING (Vomitting). On 05-Jun-2021, FATIGUE (Tiredness) and MYALGIA (Bodyaches) had resolved. At the time of the report, DIARRHOEA (Diarrhea), NAUSEA (Nauseous) and VOMITING (Vomitting) had resolved.            Action taken with mRNA-1273 in response to the drug was not applicable. No concomitant medication information was provided. No treatment medication information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: itchy; site is red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (site is red) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jun-2021, the patient experienced VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (site is red). At the time of the report, VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (site is red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.  No treatment medications provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Hypertension
Clinical narrative: high blood pressure; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (high blood pressure) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (high blood pressure). At the time of the report, HYPERTENSION (high blood pressure) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.   Treatment information not provided.
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Vaccination site induration, Vaccination site swelling, Vaccination site warmth
Clinical narrative: hard injection site; swollen injection site; warm injection site; feeling a bit heavy and weak as well; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE INDURATION (hard injection site), VACCINATION SITE SWELLING (swollen injection site), VACCINATION SITE WARMTH (warm injection site) and ASTHENIA (feeling a bit heavy and weak as well) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jun-2021, the patient experienced VACCINATION SITE INDURATION (hard injection site), VACCINATION SITE SWELLING (swollen injection site), VACCINATION SITE WARMTH (warm injection site) and ASTHENIA (feeling a bit heavy and weak as well). At the time of the report, VACCINATION SITE INDURATION (hard injection site), VACCINATION SITE SWELLING (swollen injection site), VACCINATION SITE WARMTH (warm injection site) and ASTHENIA (feeling a bit heavy and weak as well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue). At the time of the report, FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. Treatment drug information was not given.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects). At the time of the report, VACCINATION COMPLICATION (side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Reporter did not allow further contact
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired Vaccine Injected to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Injected to patient) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No Medical History information was reported.   In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jun-2021 at 9:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Injected to patient). On 08-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Injected to patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication and treatment information were not reported.
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Blood glucose abnormal
Clinical narrative: glucose level unusual; This spontaneous case was reported by a patient family member or friend and describes the occurrence of BLOOD GLUCOSE ABNORMAL (glucose level unusual) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Type II diabetes mellitus.   On 22-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLOOD GLUCOSE ABNORMAL (glucose level unusual). At the time of the report, BLOOD GLUCOSE ABNORMAL (glucose level unusual) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-May-2021, Blood glucose: abnormal (abnormal) Glucose level unusual.         Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.   Reporter did not allow further contact
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Acne, Dermatitis atopic, Myalgia
Clinical narrative: flare in dermatitis / rash got worse; face broke out in acne; arm and leg ache a lot; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DERMATITIS ATOPIC (flare in dermatitis / rash got worse), ACNE (face broke out in acne) and MYALGIA (arm and leg ache a lot) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Atopic dermatitis (had cleared up prior to the first dose of the Moderna COVID-19 vaccine on 20-Jan-2021.). Concomitant products included DOXYCYCLINE for Eye disorder NOS, LOSARTAN for Hypertension.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced DERMATITIS ATOPIC (flare in dermatitis / rash got worse), ACNE (face broke out in acne) and MYALGIA (arm and leg ache a lot). At the time of the report, DERMATITIS ATOPIC (flare in dermatitis / rash got worse), ACNE (face broke out in acne) and MYALGIA (arm and leg ache a lot) outcome was unknown.            patient's lab test data not reported. Treatment for the events included an unspecified steroid shot and steroid cream.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Severe muscle pain; This spontaneous case was reported by a non-health professional and describes the occurrence of MYALGIA (Severe muscle pain) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced MYALGIA (Severe muscle pain). The patient was treated with PARACETAMOL (TYLENOL) for Muscle pain, at an unspecified dose and frequency. At the time of the report, MYALGIA (Severe muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient received her first shot of the Moderna COVID-19 vaccine on 10March2021 and their second shot on 28April2021 and ever since have been experiencing severe muscle pain.  The pain is not going away.  Patient is not on any concomitant medication.  Treatment taken include Tylenol for severe muscle pain
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash all over body; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash all over body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form(s). On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form(s). On 23-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (rash all over body). On 08-Mar-2021, RASH (rash all over body) had resolved.            Patient  visited to her dermatologist on 24-FEB-2021  . No  concomitant medical  provided by the reporter. No treatment medication provided by the reporter.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine)  was Not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Medication error
Clinical narrative: Patient didn't receive full dose of the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of MEDICATION ERROR (Patient didn't receive full dose of the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jun-2021, the patient experienced MEDICATION ERROR (Patient didn't receive full dose of the vaccine). At the time of the report, MEDICATION ERROR (Patient didn't receive full dose of the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided.   No treatment medication were provided.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Hangover, Headache, Malaise, Myalgia, Pyrexia
Clinical narrative: Feeling sick; feels like a bad hangover; body aches; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling sick), HANGOVER (feels like a bad hangover), MYALGIA (body aches), PYREXIA (fever) and HEADACHE (headache) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (Feeling sick), HANGOVER (feels like a bad hangover), MYALGIA (body aches), PYREXIA (fever) and HEADACHE (headache). At the time of the report, MALAISE (Feeling sick), HANGOVER (feels like a bad hangover), MYALGIA (body aches), PYREXIA (fever) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment was reported.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: pain in both shoulders; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (pain in both shoulders) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (pain in both shoulders). At the time of the report, ARTHRALGIA (pain in both shoulders) outcome was unknown.            no treatment medication and concomitant medication reported.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Nasal congestion, Rhinorrhoea
Clinical narrative: Runny nose; Congestion; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose) and NASAL CONGESTION (Congestion) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jun-2021, the patient experienced RHINORRHOEA (Runny nose) and NASAL CONGESTION (Congestion). The patient was treated with FEXOFENADINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE (ALLEGRA D) at an unspecified dose and frequency. At the time of the report, RHINORRHOEA (Runny nose) and NASAL CONGESTION (Congestion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site rash, Vaccination site urticaria
Clinical narrative: Rashes under the breast/rashes in the inner thighs/3rd of her whole body had rashes; Hives around the injection site; rashes and hives around the injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH (Rashes under the breast/rashes in the inner thighs/3rd of her whole body had rashes), VACCINATION SITE URTICARIA (Hives around the injection site) and VACCINATION SITE RASH (rashes and hives around the injection site) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, the patient experienced RASH (Rashes under the breast/rashes in the inner thighs/3rd of her whole body had rashes), VACCINATION SITE URTICARIA (Hives around the injection site) and VACCINATION SITE RASH (rashes and hives around the injection site). At the time of the report, RASH (Rashes under the breast/rashes in the inner thighs/3rd of her whole body had rashes), VACCINATION SITE URTICARIA (Hives around the injection site) and VACCINATION SITE RASH (rashes and hives around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment was reported for the events.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: A 16 year old patient was administered the first dose of the Moderna COVID-19 vaccine.; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 16 year old patient was administered the first dose of the Moderna COVID-19 vaccine.) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024C21A and 002C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 16 year old patient was administered the first dose of the Moderna COVID-19 vaccine.). On 08-Jun-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 16 year old patient was administered the first dose of the Moderna COVID-19 vaccine.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Treatment information was not reported.    Most recent FOLLOW-UP information incorporated above includes: On 10-Aug-2021: followup received: Second dose details, patient demographics were added
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Vaccination site erythema
Clinical narrative: Headache; Chills; Fatigue; Sore muscle; injection site was sore /  injection site still feels a little tender; Injection site was red; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), CHILLS (Chills), FATIGUE (Fatigue), MYALGIA (Sore muscle) and VACCINATION SITE PAIN (injection site was sore /  injection site still feels a little tender) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included CITALOPRAM and CLONAZEPAM for an unknown indication.   On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced HEADACHE (Headache), CHILLS (Chills), FATIGUE (Fatigue), MYALGIA (Sore muscle), VACCINATION SITE PAIN (injection site was sore /  injection site still feels a little tender) and VACCINATION SITE ERYTHEMA (Injection site was red). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (Headache), CHILLS (Chills), FATIGUE (Fatigue), MYALGIA (Sore muscle), VACCINATION SITE PAIN (injection site was sore /  injection site still feels a little tender) and VACCINATION SITE ERYTHEMA (Injection site was red) outcome was unknown. Not Provided          Action taken with mRNA-1273 in response to the event was not applicable.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Headache; Chills; Fatigue; Sore muscle; injection site was sore /  injection site still feels a little tender; Injection site was red; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), CHILLS (Chills), FATIGUE (Fatigue), MYALGIA (Sore muscle) and VACCINATION SITE PAIN (injection site was sore /  injection site still feels a little tender) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included CITALOPRAM and CLONAZEPAM for an unknown indication.   On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced HEADACHE (Headache), CHILLS (Chills), FATIGUE (Fatigue), MYALGIA (Sore muscle), VACCINATION SITE PAIN (injection site was sore /  injection site still feels a little tender) and VACCINATION SITE ERYTHEMA (Injection site was red). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (Headache), CHILLS (Chills), FATIGUE (Fatigue), MYALGIA (Sore muscle), VACCINATION SITE PAIN (injection site was sore /  injection site still feels a little tender) and VACCINATION SITE ERYTHEMA (Injection site was red) outcome was unknown. Not Provided          Action taken with mRNA-1273 in response to the event was not applicable.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient received 2nd dose 18 days after 1st dose; This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received 2nd dose 18 days after 1st dose) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014C21A and 027C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received 2nd dose 18 days after 1st dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received 2nd dose 18 days after 1st dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenitis, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: Injection site they hurt; Her lymph nodes inflamed under her left armpit, her lymph nodes inflamed her clavicle, they got bigger, they continue to be there; Fever; Muscle ache; Headache; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENITIS (Her lymph nodes inflamed under her left armpit, her lymph nodes inflamed her clavicle, they got bigger, they continue to be there), VACCINATION SITE PAIN (Injection site they hurt), PYREXIA (Fever), MYALGIA (Muscle ache) and HEADACHE (Headache) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical information provided by the reporter.  Concomitant products included AMLODIPINE BESILATE (NORVASC) for an unknown indication.   On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced PYREXIA (Fever), MYALGIA (Muscle ache) and HEADACHE (Headache). On 10-Apr-2021, the patient experienced LYMPHADENITIS (Her lymph nodes inflamed under her left armpit, her lymph nodes inflamed her clavicle, they got bigger, they continue to be there). On 11-Apr-2021, the patient experienced VACCINATION SITE PAIN (Injection site they hurt). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, LYMPHADENITIS (Her lymph nodes inflamed under her left armpit, her lymph nodes inflamed her clavicle, they got bigger, they continue to be there), VACCINATION SITE PAIN (Injection site they hurt), PYREXIA (Fever), MYALGIA (Muscle ache) and HEADACHE (Headache) had resolved.            Concomitant medication includes Vitamins.  Action taken with mRNA-1273 in response to the event was not applicable.     Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Follow up received on 10-Jun-2021 contain significant information: Outcome of the event changed from unknown to recovered.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: My arm was sore for a couple of days. How should the second shot be; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (My arm was sore for a couple of days. How should the second shot be) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (My arm was sore for a couple of days. How should the second shot be). At the time of the report, MYALGIA (My arm was sore for a couple of days. How should the second shot be) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not reported. Treatment medication information was not provided.